Patent · US Active

Compositions against cancer antigen LIV-1 and uses thereof

US8906342B2 · kind B2 · utility

4Cited by
15References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 14, 2013
Grant dateDec 9, 2014
Priority date—
Expiry dateOct 14, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/505
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.